Bioassays
Bioassays are an integral part of the overall quality strategy for bio-pharmaceutical products.
Protagen AG provides the following assays:
- Cell based bioassays, e.g. proliferation, cytotoxicity
- ELISA
- Unique bioassay platform for therapeutic antibodies based on Protein Microarrays
For these assays, Protagen AG offers in close collaboration with its clients:
- GMP and non GMP analysis under highest quality standards
- Transfer and establishing of existing assays
- Optimization of bioassays using
- Design of experiments (DOE)
- Protein Microarrays for selection of specific detection antibodies
- Assay validation according to ICH Q2 (R1) and USP
- Batch release, stability and comparability testing
Protagen uniquely combines bioassays with structural and functional protein analysis:
- well accepted analytical techniques (HPLC, PAGE etc) and
- sophisticated mass spectrometry
- modern quality management techniques like risk assessment
This portfolio is completed by profound expertise in bioinformatic data analysis and statistics.
Please
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
Protagen for further information.
|
 Example: G-CSF potency assay: Determination of biological activity of G-CSF (Filgrastim) according to PharmEu monograph <2206>.
|